Patent 10864199
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Active provider: Google · gemini-2.5-flash
Proceedings on file (0)
All PTAB activity →AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.
Current assignee: Veloxis Pharmaceuticals AS
No PTAB proceedings on file. This patent has not been challenged via IPR, PGR, or CBM. The absence is itself a signal — well-asserted patents eventually attract IPRs. The LLM analysis below may surface filings the ODP feed hasn’t indexed yet.
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Proceedings overview
There are no AIA trial proceedings on file for US Patent 10864199 as of 2026-06-01. This indicates that the patent has not been subjected to challenges at the Patent Trial and Appeal Board (PTAB), meaning all claims remain untested by this adversarial review process.
Strategic summary
All claims of US10864199 are currently UNTESTED by any AIA trial proceeding before the PTAB. There are no records of Inter Partes Reviews (IPRs), Post-Grant Reviews (PGRs), or Covered Business Method (CBM) reviews having been filed against this patent. Consequently, there is no estoppel landscape established through PTAB proceedings, and all prior-art grounds remain potentially available for a defendant to assert, for instance, in district court litigation or a future PTAB challenge. The absence of PTAB activity suggests that the patent owner has not yet faced a direct validity challenge in this forum, or if challenges were considered, they were not formally filed or did not progress to institution.
Recommended next steps
Since there is no PTAB activity on file for US10864199, the recommended next steps are as follows:
- For a defendant facing assertion of this patent: Consider initiating an AIA trial proceeding (e.g., IPR or PGR, depending on the patent's effective filing date and available prior art) if a strong invalidity case can be built. The absence of prior PTAB challenges means there's no "hardened" claims to contend with, nor any estoppel on prior art grounds.
- Monitor for future filings: As the patent is active and has ongoing litigation, regularly check the USPTO PTAB E2E system for any newly filed petitions against US10864199.
- Analyze patent strength: Given the lack of PTAB review, a thorough prior art search and analysis of the patent's claims against the found art would be crucial to assess its vulnerability to future challenges.
Generated 6/1/2026, 12:48:50 AM